Skip to main content
HJRES 54 110th Congress House Health Administrative procedure Blood Cancer Congress Congressional veto Department of Health and Human Services Government Operations and Politics Law Medicare Social Welfare

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human…

Show full title

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.

Introduced: September 27, 2007 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 110th Congress ended
It never became law before the 110th Congress (2007–2008) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 8, 2007
Referred to the Subcommittee on Health.
Oct 3, 2007
Referred to the Subcommittee on Health.
Sep 27, 2007
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 27, 2007
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Disapproves a specified rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.

Declares that such rule shall have no force or effect.

What's happening now November 8, 2007

Referred to the Subcommittee on Health.

 Related & companion bills 1
  • SJRES 22 Identical bill A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule…
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 13
All 13 Democratic 4 Republican 9
D
Costa, Jim
California · Dec 12, 2007
 R
Lucas, Frank D.
Oklahoma · Dec 5, 2007
 R
McCaul, Michael T.
Texas · Nov 7, 2007
 R
Blackburn, Marsha
Tennessee · Nov 6, 2007
 R
Cole, Tom
Oklahoma · Nov 1, 2007
 R
Bilirakis, Gus M.
Florida · Oct 17, 2007
 D
Courtney, Joe
Connecticut · Oct 17, 2007
 R
Aderholt, Robert B.
Alabama · Oct 12, 2007
 R
Buchanan, Vern
Florida · Oct 12, 2007
 D
Nadler, Jerrold
New York · Oct 12, 2007
 D
Bishop, Sanford D.
Georgia · Oct 4, 2007
 R
Sessions, Pete
Texas · Oct 4, 2007
 R
Walberg, Tim
Michigan · Oct 4, 2007
Cite this page click to expand
APA
U.S. Congress. (2026). H.J. Res. 54: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.. 110th Congress. Open America. https://openamerica.io/bill/110-HJRES-54/
MLA
"H.J. Res. 54: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.." 110th Congress, 2026, Open America, https://openamerica.io/bill/110-HJRES-54/.
Bluebook (legal)
H.J. Res. 54, 110th Cong. (2026), https://openamerica.io/bill/110-HJRES-54/.
Markdown link
[H.J. Res. 54: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.](https://openamerica.io/bill/110-HJRES-54/)
Report a problem